Nubilaria

Nubilaria

Milan, Italy· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $1.8M

Overview

Nubilaria is a Milan-based IT services firm with a 20-year history, originally founded in 2004, not 2019 as some records indicate. It operates as a data specialist, building custom software and managing data pipelines for large clients in banking (e.g., SWIFT) and healthcare (via its ACTide solution). The company's business model is centered on providing data services and governance, not on developing microbiome-based therapeutics. There is a significant discrepancy between the provided company data (suggesting a biotech focus) and the actual website content, which reveals a mature IT consultancy.

MicrobiomeMetabolic

Technology Platform

Enterprise data lifecycle management platform specializing in collection, management, insight, security, and governance for regulated industries. Expertise includes big data handling, data modeling, and integration of AI/ML within strict compliance frameworks.

Funding History

1
Total raised:$1.8M
Seed$1.8M

Opportunities

Growing demand for secure, compliant data management in finance (digital transactions, cybersecurity) and healthcare (data-driven medicine, clinical trials).
Long-term client relationships provide a stable base for cross-selling advanced analytics and AI-enabled services.

Risk Factors

High dependence on key clients like SWIFT creates concentration risk.
The fast pace of technological change requires constant investment to remain competitive.
As a data custodian, it faces existential threats from major cybersecurity breaches.

Competitive Landscape

Competes with large global IT consultancies (e.g., Accenture, IBM), specialized data management firms, and in-house IT departments of large banks and healthcare providers. Differentiation is based on deep, niche expertise in SWIFT protocols and clinical data management, long-term partnership models, and strict compliance adherence.